STOCK TITAN

[S-8 POS] Streamline Health Solutions, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Streamline Health Solutions, Inc. reports that, pursuant to an Agreement and Plan of Merger dated May 29, 2025, Merger Sub merged with and into the Company on August 12, 2025, with the Company surviving the Merger as a wholly owned subsidiary of the Parent company (Mist Holding Co.). As a consequence of the Merger, the Company has terminated its offerings under its existing Form S-8 registration statements and has filed post-effective amendments to remove from registration any shares that remain unsold under those Registration Statements.

The filing notes that previously registered share amounts have not been adjusted to reflect the 1-for-15 reverse stock split effected October 4, 2024, and lists multiple prior Form S-8 registrations, including a 2024 registration totaling 6,738,902 shares.

Streamline Health Solutions, Inc. comunica che, ai sensi di un Agreement and Plan of Merger datato 29 maggio 2025, Merger Sub si è fusa con e nella Società il 12 agosto 2025, con la Società che è sopravvissuta alla fusione come controllata interamente posseduta dalla capogruppo Mist Holding Co. Di conseguenza, la Società ha interrotto le offerte previste dalle sue attuali dichiarazioni di registrazione Form S-8 e ha presentato emendamenti post-effectivi per rimuovere dalla registrazione le azioni rimaste invendute ai sensi di tali dichiarazioni.

Il documento rileva che gli importi delle azioni precedentemente registrate non sono stati adeguati per riflettere lo split inverso 1-per-15 effettuato il 4 ottobre 2024, e elenca più registrazioni Form S-8 precedenti, inclusa una registrazione del 2024 per un totale di 6,738,902 azioni.

Streamline Health Solutions, Inc. informa que, conforme al Agreement and Plan of Merger fechado el 29 de mayo de 2025, Merger Sub se fusionó con y en la Compañía el 12 de agosto de 2025, y la Compañía sobrevivió a la fusión como subsidiaria propiedad total de la matriz Mist Holding Co. Como consecuencia de la fusión, la Compañía ha terminado sus ofertas bajo sus actuales declaraciones de registro Form S-8 y ha presentado enmiendas post-efectivas para retirar de la registración las acciones que permanezcan sin vender bajo esas declaraciones.

La presentación señala que las cantidades de acciones previamente registradas no se han ajustado para reflejar la consolidación inversa de acciones 1-por-15 realizada el 4 de octubre de 2024, y enumera varias registraciones previas Form S-8, incluida una registración de 2024 que totaliza 6,738,902 acciones.

Streamline Health Solutions, Inc.는 2025년 5월 29일자 Agreement and Plan of Merger에 따라 Merger Sub가 2025년 8월 12일 회사와 합병되었고, 회사는 모회사 Mist Holding Co.의 전액 출자 자회사로서 합병 후에도 존속한다고 보고했습니다. 이에 따라 회사는 기존 Form S-8 등록명세서에 따른 공모를 종료하고, 해당 등록명세서에 따라 미판매로 남아 있는 주식을 등록에서 제외하기 위한 사후 효력 변경서(post-effective amendments)를 제출했습니다.

해당 제출서류는 이전에 등록된 주식 수량이 2024년 10월 4일 시행된 1대15 역병합(reverse stock split)을 반영하여 조정되지 않았음을 지적하며, 2024년 등록분 6,738,902주를 포함한 여러 이전 Form S-8 등록을 열거하고 있습니다.

Streamline Health Solutions, Inc. rapporte que, conformément à un Agreement and Plan of Merger daté du 29 mai 2025, Merger Sub a fusionné avec et dans la Société le 12 août 2025, la Société subsistant à la fusion en tant que filiale détenue à 100 % par la société mère Mist Holding Co. Par conséquent, la Société a mis fin à ses offres au titre de ses déclarations d'enregistrement Form S-8 existantes et a déposé des amendements post-efficacité visant à retirer de l'enregistrement les actions restant invendues au titre de ces déclarations.

Le dépôt indique que les montants d'actions précédemment enregistrés n'ont pas été ajustés pour refléter le reverse stock split 1-for-15 effectué le 4 octobre 2024, et énumère plusieurs enregistrements antérieurs Form S-8, y compris un enregistrement de 2024 totalisant 6,738,902 actions.

Streamline Health Solutions, Inc. teilt mit, dass gemäß einem Agreement and Plan of Merger vom 29. Mai 2025 die Merger Sub am 12. August 2025 mit der Gesellschaft verschmolzen wurde und die Gesellschaft als hundertprozentige Tochtergesellschaft der Muttergesellschaft Mist Holding Co. aus der Fusion hervorgegangen ist. Infolgedessen hat die Gesellschaft ihre Angebote im Rahmen der bestehenden Form S-8-Registrierungserklärungen eingestellt und nachwirkende Änderungen eingereicht, um nicht verkaufte Aktien aus der Registrierung zu streichen.

Die Einreichung weist darauf hin, dass die zuvor registrierten Aktienbeträge nicht angepasst wurden, um den am 4. Oktober 2024 durchgeführten Reverse-Stock-Split im Verhältnis 1:15 zu berücksichtigen, und listet mehrere frühere Form S-8-Registrierungen auf, darunter eine Registrierung aus 2024 mit insgesamt 6,738,902 Aktien.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: The Merger closed, converting the registrant into a wholly owned subsidiary and triggering termination and deregistration of outstanding S-8 offerings.

The document evidences a completed merger in which Merger Sub merged into the registrant with the registrant surviving as a wholly owned subsidiary of the Parent. That corporate change is material because it directly ended the registrant's registered public offerings under multiple Form S-8 statements and required post-effective amendments to withdraw unsold shares from registration. The filing also records that historical S-8 share tallies were not adjusted for the prior 1-for-15 reverse split, which is important for reconciling pre- and post-split disclosure. This is a substantive corporate-event filing rather than an operational or financial disclosure.

TL;DR: Procedural deregistration completed to satisfy prior registration undertakings following a change in corporate ownership.

The post-effective amendments perform a compliance function: they implement the registrant's undertaking to remove from registration any unsold securities when offerings terminate. The filing lists the affected Form S-8 registrations and confirms the administrative step of deregistration after a change in control. From a governance perspective this is routine post-transaction housekeeping, but it signifies a change in the registrant's capital markets status that stakeholders should note when reviewing equity-compensation and registration history.

Streamline Health Solutions, Inc. comunica che, ai sensi di un Agreement and Plan of Merger datato 29 maggio 2025, Merger Sub si è fusa con e nella Società il 12 agosto 2025, con la Società che è sopravvissuta alla fusione come controllata interamente posseduta dalla capogruppo Mist Holding Co. Di conseguenza, la Società ha interrotto le offerte previste dalle sue attuali dichiarazioni di registrazione Form S-8 e ha presentato emendamenti post-effectivi per rimuovere dalla registrazione le azioni rimaste invendute ai sensi di tali dichiarazioni.

Il documento rileva che gli importi delle azioni precedentemente registrate non sono stati adeguati per riflettere lo split inverso 1-per-15 effettuato il 4 ottobre 2024, e elenca più registrazioni Form S-8 precedenti, inclusa una registrazione del 2024 per un totale di 6,738,902 azioni.

Streamline Health Solutions, Inc. informa que, conforme al Agreement and Plan of Merger fechado el 29 de mayo de 2025, Merger Sub se fusionó con y en la Compañía el 12 de agosto de 2025, y la Compañía sobrevivió a la fusión como subsidiaria propiedad total de la matriz Mist Holding Co. Como consecuencia de la fusión, la Compañía ha terminado sus ofertas bajo sus actuales declaraciones de registro Form S-8 y ha presentado enmiendas post-efectivas para retirar de la registración las acciones que permanezcan sin vender bajo esas declaraciones.

La presentación señala que las cantidades de acciones previamente registradas no se han ajustado para reflejar la consolidación inversa de acciones 1-por-15 realizada el 4 de octubre de 2024, y enumera varias registraciones previas Form S-8, incluida una registración de 2024 que totaliza 6,738,902 acciones.

Streamline Health Solutions, Inc.는 2025년 5월 29일자 Agreement and Plan of Merger에 따라 Merger Sub가 2025년 8월 12일 회사와 합병되었고, 회사는 모회사 Mist Holding Co.의 전액 출자 자회사로서 합병 후에도 존속한다고 보고했습니다. 이에 따라 회사는 기존 Form S-8 등록명세서에 따른 공모를 종료하고, 해당 등록명세서에 따라 미판매로 남아 있는 주식을 등록에서 제외하기 위한 사후 효력 변경서(post-effective amendments)를 제출했습니다.

해당 제출서류는 이전에 등록된 주식 수량이 2024년 10월 4일 시행된 1대15 역병합(reverse stock split)을 반영하여 조정되지 않았음을 지적하며, 2024년 등록분 6,738,902주를 포함한 여러 이전 Form S-8 등록을 열거하고 있습니다.

Streamline Health Solutions, Inc. rapporte que, conformément à un Agreement and Plan of Merger daté du 29 mai 2025, Merger Sub a fusionné avec et dans la Société le 12 août 2025, la Société subsistant à la fusion en tant que filiale détenue à 100 % par la société mère Mist Holding Co. Par conséquent, la Société a mis fin à ses offres au titre de ses déclarations d'enregistrement Form S-8 existantes et a déposé des amendements post-efficacité visant à retirer de l'enregistrement les actions restant invendues au titre de ces déclarations.

Le dépôt indique que les montants d'actions précédemment enregistrés n'ont pas été ajustés pour refléter le reverse stock split 1-for-15 effectué le 4 octobre 2024, et énumère plusieurs enregistrements antérieurs Form S-8, y compris un enregistrement de 2024 totalisant 6,738,902 actions.

Streamline Health Solutions, Inc. teilt mit, dass gemäß einem Agreement and Plan of Merger vom 29. Mai 2025 die Merger Sub am 12. August 2025 mit der Gesellschaft verschmolzen wurde und die Gesellschaft als hundertprozentige Tochtergesellschaft der Muttergesellschaft Mist Holding Co. aus der Fusion hervorgegangen ist. Infolgedessen hat die Gesellschaft ihre Angebote im Rahmen der bestehenden Form S-8-Registrierungserklärungen eingestellt und nachwirkende Änderungen eingereicht, um nicht verkaufte Aktien aus der Registrierung zu streichen.

Die Einreichung weist darauf hin, dass die zuvor registrierten Aktienbeträge nicht angepasst wurden, um den am 4. Oktober 2024 durchgeführten Reverse-Stock-Split im Verhältnis 1:15 zu berücksichtigen, und listet mehrere frühere Form S-8-Registrierungen auf, darunter eine Registrierung aus 2024 mit insgesamt 6,738,902 Aktien.

As filed with the Securities and Exchange Commission on August 14, 2025

 

Registration No. 333-280444

Registration No. 333-188764

Registration No. 333-208752

Registration No. 333-220953

Registration No. 333-233728

Registration No. 333-258445

Registration No. 333-265774

Registration No. 333-272995

 



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-280444

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-188764

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-208752

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-220953

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-233728

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-258445

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-265774

Post-Effective Amendment No. 1 to Form S-8 Registration No. 333-272995

 

UNDER

THE SECURITIES ACT OF 1933

 


 

STREAMLINE HEALTH SOLUTIONS, INC.

(Exact Name of Registrant as Specified in its Charter)

 


 

Delaware

 

0-28132

 

31-1455414

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission File Number)

 

(I.R.S. Employer

Identification No.)

         

2400 Old Milton Pkwy., Box 1353

Alpharetta, GA 30009

(203) 883-9490

(Address of Principal Executive Offices) (Zip Code)

 

Streamline Health Solutions, Inc. 2025 Omnibus Incentive Compensation Plan
Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan

(Full title of the plans)

 

 

Bryant J. Reeves, III

 

Chief Financial Officer

2400 Old Milton Pkwy., Box 1353

Alpharetta, Georgia 30009

(888) 997-8732

 

(Name and address of agent for service) (Telephone number, including area code, of agent for service)

 

 

 

 

Copies to:

David W. Ghegan

Cody M. Mathis

Troutman Pepper Locke LLP

600 Peachtree Street NE, Suite 3000

Atlanta, Georgia 30308

(404) 885-3139

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

               

Large accelerated filer

 

 

Accelerated filer

     
         

Non-accelerated filer

 

x

 

Smaller reporting company

 

x

 
         
       

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 



 

 


 

 

 

EXPLANATORY NOTE DEREGISTRATION OF SECURITIES

 

These Post-Effective Amendments (these “Post-Effective Amendments”) relate to the following Registration Statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”), filed with the Securities and Exchange Commission (the “SEC”) by Streamline Health Solutions, Inc., a Delaware corporation (the “Registrant”):

 

 

Registration Statement on Form S-8 (No. 333‑188764), filed with the SEC on May 22, 2013, pertaining to the registration of 2,000,000 shares of common stock, par value $0.01 per share (“Common Stock”) of the Registrant reserved for issuance under the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan (the “2013 Plan”);

 

 

Registration Statement on Form S-8 (No. 333‑208752), filed with the SEC on December 24, 2015, pertaining to the registration of (i) an additional 1,600,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 300,000 shares of Common Stock issuable upon the exercise of new employee inducement stock option awards;

 

 

Registration Statement on Form S-8 (No. 333‑220953), filed with the SEC on October 13, 2017, pertaining to the registration of (i) an additional 300,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 75,000 shares of Common Stock issuable upon the exercise of a new employee inducement stock option award;

 

 

Registration Statement on Form S-8 (No. 333‑233728), filed with the SEC on September 12, 2019, pertaining to the registration of (i) an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan and (ii) 225,000 shares of Common Stock issuable under new-employee inducement restricted stock awards;

 

 

Registration Statement on Form S-8 (No. 333‑258445), filed with the SEC on August 4, 2021, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑265774), filed with the SEC on June 22, 2022, pertaining to the registration of an additional 2,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan;

 

 

Registration Statement on Form S-8 (No. 333‑272995), filed with the SEC on June 28, 2023, pertaining to the registration of an additional 1,000,000 shares of Common Stock of the Registrant reserved for issuance under the 2013 Plan; and

 

 

Registration Statement on Form S-8 (No. 333‑280444), filed with the SEC on June 24, 2024, pertaining to the registration of 6,738,902 shares of Common Stock of the Registrant, which consists of (i) 6,000,000 shares of Common Stock reserved for issuance under the Streamline Health Solutions, Inc. 2024 Omnibus Incentive Compensation Plan (the “2024 Plan”) and (ii) 738,902 shares of Common Stock available for issuance (or which may become available for issuance) under the 2013 Plan.

 

The number of shares of Common Stock registered under the Registration Statements set forth above have not been adjusted to reflect the 1-for-15 reverse stock split of the issued and outstanding shares of Common Stock effected by the Company on October 4, 2024.

 

On August 12, 2025, pursuant to the terms of the Agreement and Plan of Merger, dated May 29, 2025, by and among the Registrant, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly owned subsidiary of Parent.

 

As a result of the Merger, the Registrant has terminated, as of the date hereof, all offerings of its securities pursuant to its existing registration statements under the Securities Act of 1933, as amended (the “Securities Act”), including the Registration Statements. In accordance with an undertaking made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities which remain unsold at the termination of the offering, Registrant hereby removes and withdraws from registration all securities of the Registrant registered pursuant to the Registration Statements that remain unsold as of the date hereof, and the Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities. 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Atlanta, State of Georgia, on August 14, 2025. No other person is required to sign these Post-Effective Amendments to the Registration Statements on Form S-8 in reliance on Rule 478 of the Securities Act

 

STREAMLINE HEALTH SOLUTIONS, INC.

 

 

By: /s/ Nick Barnes                                             

Nick Barnes

Chief Financial Officer, Treasurer and Secretary 

 

 


 

 
Streamline Health Solutions In

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

23.23M
3.60M
17.45%
26.05%
0.51%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
ALPHARETTA